Evolution of the E2 region of hepatitis C virus in an infant infectedby mother-to-infant transmission

Giovanni Sitia(Vita-Salute San Raffaele University), Giulia Morsica(Vita-Salute San Raffaele University), K. Perackis(University of Milan), Caterina Uberti‐Foppa(Vita-Salute San Raffaele University), Maria Stella De Mitri(University of Bologna), Adriano Lazzarin(Vita-Salute San Raffaele University), A De Bona, D. Cella(University of Milan)
Journal of Hepatology
January 1, 2000
10.1016/s0168-8278(00)81067-3
Cited by 0

Related Papers

Efficacy of Enfuvirtide in Patients Infected with Drug-Resistant HIV-1 in Europe and Australia
|New England Journal of Medicine|2003|653
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
|The Lancet|2009|620
Hepatitis C viraemia and liver disease in symptom-free individuals with anti-HCV
|The Lancet|1992|393
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors
|Clinical Microbiology and Infection|2020|391
Human Papillomavirus Infection and Associated Cervical Disease in Human Immunodeficiency Virus–Infected Women: Effect of Highly Active Antiretroviral Therapy
|The Journal of Infectious Diseases|2001|173